Sign up for the QMED & MD+DI Daily newsletter.
Covidien to Acquire Somanetics Corp.
Dublin-based Covidien announced on its Web site that it has signed a merger agreement with Somanetics Corp. (Troy, MI). Under the agreement, Covidien will acquire all outstanding shares of Somanetics for a total of $250 million, net of cash acquired.
June 17, 2010
1 Min Read
.svg?width=1280&auto=webp&quality=95&format=jpg&disable=upscale "MDDI")
Somanetics makes cerebal and somatic oximetry products, including the In-Vivo Optical Spectroscopy. Covidien says that the acquisition of the manufacturer will enable it to "add another market-leading technology to its portfolio."
The transaction is expected to be completed by July 31, 2010.
You May Also Like
.png?width=700&auto=webp&quality=80&disable=upscale)
